NCT04470167View on ClinicalTrials.gov

Phase 1/2 Clinical Study of TPX-115 in Patients With Partial-Thickness Rotator Cuff Tear

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

October 26, 2020

Primary Completion Date

February 17, 2022

Study Completion Date

February 17, 2022

Conditions
Rotator Cuff Injuries
Interventions
BIOLOGICAL

TPX-115

Ultrasound-guided intratendinous injection of allogeneic fibroblasts(TPX-115)

OTHER

Placebo

Ultrasound-guided intratendinous placebo injection

Trial Locations (2)

13620

Seoul National University Bundang Hospital, Seongnam-si

03080

Seoul National University Hospital, Seoul

All Listed Sponsors
lead

Tego Science, Inc.

INDUSTRY

NCT04470167 - Phase 1/2 Clinical Study of TPX-115 in Patients With Partial-Thickness Rotator Cuff Tear | Biotech Hunter | Biotech Hunter